TriSalus Life Sciences® Inc., (Nasdaq: TLSI), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, is ...
InVera Medical receives US FDA 510(k) clearance for InVera Infusion Device, a novel non-thermal catheter for enhanced ...
The VENUS trial results, which demonstrated a benefit of adding an ethanol infusion to the vein of Marshall during catheter ablation of persistent atrial fibrillation (AF), are now published. The ...
InVera Medical announced today that it has received FDA 510(k) clearance for its InVera Infusion Device system.
In addition, infusion procedures frequently follow other care appointments, making it a challenge to successfully manage a complex, constantly changing schedule. Solutions based on mathematical ...
MANHATTAN, Kan. (WIBW) - The out-patient clinic at Ascension Via Christi in Manhattan treated seven patients Thursday with COVID-19 antibody infusions, in hopes to reduce the severity of symptoms.
InVera Medical, a medical device company focused on advancing minimally-invasive technologies for Chronic Venous Disease, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results